Janet Wolter
- Oncology top 0.1%
- Radiology, Nuclear Medicine and Imaging top 0.1%
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Co-authors
- Steven ShakDennis J. SlamonVirginia PatonW. EiermannJosé BaselgaMark D. PegramThomas FlemingBrian Leyland‐Jones
- Topics
- Cancer Treatment and Pharmacology (8 papers)Estrogen and related hormone effects (8 papers)Breast Cancer Treatment Studies (5 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologyThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Janet Wolter
30 papers receiving 11.9k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 9.2k
- Radiology, Nuclear Medicine and Imaging 4.1k
- Molecular Biology 3.2k
- Cancer Research 2.9k
- Pulmonary and Respiratory Medicine 2.3k
Countries citing papers authored by Janet Wolter
This map shows the geographic impact of Janet Wolter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Wolter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Wolter more than expected).
Fields of papers citing papers by Janet Wolter
This network shows the impact of papers produced by Janet Wolter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Wolter. The network helps show where Janet Wolter may publish in the future.
Co-authorship network of co-authors of Janet Wolter
This figure shows the co-authorship network connecting the top 25 collaborators of Janet Wolter. A scholar is included among the top collaborators of Janet Wolter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Wolter. Janet Wolter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2breakdown → | 8436 |
| 2 | Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Diseasebreakdown → | 2174 |
| 3 | 129 | |
| 4 | 143 | |
| 5 | 51 | |
| 6 | 88 | |
| 7 | 1 | |
| 8 | 63 | |
| 9 | 84 | |
| 10 | 29 | |
| 11 | 25 | |
| 12 | 5 | |
| 13 | 2 | |
| 14 | 2 | |
| 15 | 12 | |
| 16 | 70 | |
| 17 | 41 | |
| 18 | 67 | |
| 19 | 59 | |
| 20 | 129 |
About Janet Wolter
Janet Wolter is a scholar working on Oncology, Cancer Research and Genetics, having authored 30 papers that have together received 12.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Estrogen and related hormone effects (8 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Oncology (9.2k citations), Cancer Research (2.9k citations) and Radiology, Nuclear Medicine and Imaging (4.1k citations). Janet Wolter has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Steven Shak, Dennis J. Slamon, Virginia Paton, W. Eiermann, José Baselga, Mark D. Pegram, Thomas Fleming, Brian Leyland‐Jones, Larry Norton and Alex Bajamonde. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.